Bullfrog AI Holdings, Inc. Common Stock (BFRG) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Healthcare Information Services 行业. 公司总部位于 Gaithersburg, MD, 美国. 现任CEO为 Vininder Singh.
BFRG 拥有 IPO日期为 2023-02-13, 4 名全职员工, 在 NASDAQ Capital Marke, 市值为 $9.94M.
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
